Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

242025-11

THE WRITTEN CONSENT OF KINGSWAY CAPITAL LIMITED REFERRED
242025-11

THE LETTER FROM THE INDEPENDENT BOARD COMMITTEE
242025-11

THE LETTER FROM THE INDEPENDENT BOARD COMMITTEE
242025-11

THE NEW FRAMEWORK LOAN AGREEMENT
242025-11

FORM OF PROXY FOR USE AT THE 2025 EXTRAORDINARY GENERAL MEETING TO BE HELD ON 12 DECEMBER 2025 OR AT ANY ADJOURNMENT THEREOF
242025-11

NOTICE OF EXTRAORDINARY GENERAL MEETING
242025-11

(1) RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK LOAN AGREEMENT; (2) ABOLITION OF BOARD OF SUPERVISORS, PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND PROPOSED AMENDMENTS TO THE RELATED CORPORATE GOVERNANCE POLICES; (3) PROPOSED CHANGE OF AUDITORS; AND (4) NOTICE OF EXTRAORDINARY GENERAL MEETING
062025-11

PROPOSED CHANGE OF AUDITORS
032025-11

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
202025-10

(1)PROPOSED ABOLISHMENT OF THE BOARD OF SUPERVISORS; AND (2)PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE RELATED CORPORATE GOVERNANCE POLICIES
202025-10

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK LOAN AGREEMENT
022025-10

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025

1 2 3 4 5

The Enterprise OA